Our Regulatory Approvals

Leading-edge Facility with Global Standard

USFDA EU-GMP CERTIFIED (GUJARAT, INDIA)

Brooks Steriscience's state-of-the-art manufacturing facility is compliant with cGMP standards, adhering to both national and international regulations. These facilities, dedicated to the production of Carbapenem Injections and APIs, have received approvals from major international regulatory agencies, including the US FDA, MHRA (UK), Federal Ministry of Health-Germany, SAPHRA (South Africa), Department of Health (Canada), INVIMA (Colombia), ANVISA (Brazil), WHO, and various other national health ministries.With over 75+ marketing authorizations across the globe, the company's product portfolio includes innovative and vertically integrated formulations.
Brooks Steriscience Ltd , one of the largest manufacturing unit for Carbapenems Injection in India, offers a wide range of Carbapenem Injectables including :

Meropenem 500mg/1g/2g
Imipenem + Cilastatin
Doripenem 500mg
Ertapenem 1g

BROOKS STERISCIENCE

Advancing Global Health with Quality Pharmaceuticals

In the pursuit of better healthcare outcomes, we are dedicated to providing high-quality Carbapenem antibiotics—essential product in combating severe bacterial infections. Our advanced manufacturing capabilities and stringent quality standards ensure the production of these critical life-saving medicines.

Our portfolio of Carbapenem injectables, designed to meet global healthcare needs and by delivering these powerful antibiotics to healthcare providers worldwide, we are addressing some of the most challenging infections, advancing patient care, and shaping a healthier future for all.

SPECIALISED API OFFERINGS

Elevating Global Health with Advanced API Solutions

At our state-of-the-art facility, BSL excels in manufacturing high-quality Carbapenems and it's Active Pharmaceutical Ingredients (APIs), including Meropenem, Imipenem Cilastatin, Ertapenem, and Doripenem. With the recent inauguration of an advanced API facility, we have expanded our capabilities to manufacture carbapenems while achieving seamless vertical integration.
This strategic development underscores our unwavering commitment to quality, innovation, and excellence in pharmaceutical production.

Our Vision:
Our Vision is to integrate massive production capacity, cutting-edge technology, and rigorous quality control measures, ensuring superior pharmaceutical solutions that consistently exceed industry standards.

Capacity:
The plant has massive production capacity, capable of producing 50 million vials per year